Shehzad Sami is a Cardiology physician affiliated with Memorial Hermann. OpenAlex indexes 9 publications with 341 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
23 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year20254 payments
- Novartis Pharmaceuticals CorporationProgram year20253 payments
- Shockwave Medical, IncProgram year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
82.7%Beta blocker21.8%Metoprolol Tartrate52%Metoprolol Succinate22%Atenolol19%Carvedilol7%Part D≥243 patientsAngiotensin receptor blocker (ARB)14.3%Valsartan81%Losartan Potassium9%Valsartan-Hydrochlorothiazide7%Olmesartan Medoxomil2%Losartan-Hydrochlorothiazide2%Part D<11 patients+ 14 more classes in this area
Blood & clotting
11.4%P2Y12 inhibitor6.1%Clopidogrel65%Prasugrel Hcl23%Brilinta12%Part D≥77 patientsFactor Xa inhibitor5.3%Eliquis79%Xarelto21%Part D≥70 patientsMetabolism & gastrointestinal
5.7%Proton pump inhibitor3.5%Pantoprazole Sodium74%Omeprazole22%Esomeprazole Magnesium5%Part D<11 patientsPotassium supplement2%Potassium Chloride92%Klor-Con M208%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Safety and efficacy of coil embolization of the septal perforator for septal ablation in patients with hypertrophic obstructive cardiomyopathy
Catheterization and Cardiovascular Interventions
2016 - TCT-64 Coil Embolization for Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy. Long-Term Results
Journal of the American College of Cardiology
2014 - SINGLE NUCLEOTIDE POLYMORPHISMS IN CHROMOSOME 4Q25 PREDICT IN-HOSPITAL AND LONG TERM DEVELOPMENT OF ATRIAL FIBRILLATION AND SURVIVAL IN PATIENTS UNDERGOING CORONARY ARTERY BYPASS GRAFTING
Journal of the American College of Cardiology
2011
Similar KOLs
Other experts from the same institution or the same specialty.
Sunil Krishnan, MD
Memorial Hermann
Kenneth Gould, MD
Memorial Hermann
Hope Northrup, MD
Memorial Hermann
Anthony Estrera, MD
Memorial Hermann
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”